Lybrate Logo
Get the App
For Doctors
Login/Sign-up
tab_logos
About
tab_logos
Feed
Overview

Razumab 2.3Mg Injection

Manufacturer :  Intas Pharmaceuticals Ltd
Medicine Composition :  Ranibizumab
Prescription vs OTC : Prescription by Doctor required

About Razumab 2.3Mg Injection

Razumab 2.3Mg Injection is a type of anti-angiogenic that is used in the treatment of wet kind of age related macular degeneration (AMD) that doesn't allow you to see staright ahead. It is also used in treatment of macular edema, diabetic macular edema, diabetic retinopathy.

You should consult your doctor before taking Razumab 2.3Mg Injection if you are allergic to it or any of its ingredients, taking any other medicine or supplements, have an infection around your eyes, are pregnant or plan on becoming pregnant, or are breastfeeding. Also, you should not drive after taking Razumab 2.3Mg Injection.

The side effects you may experience after taking Razumab 2.3Mg Injection includes headache, teary eyes, nausea, itchy eyes, eye redness, eye pain, changes in vision, swelling of eye or eyelids, difficulty in speech, shortness of breath, chest pain. You should immediately see a doctor if the symptoms are severe or if they persist for long.

Razumab 2.3Mg Injection is available only as a liqiud solution. It should always be administered by a doctor, usually once in every month, and the treatment should continue as long as prescribed by the doctor.

    Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Ophthalmologist before using this medicine.

    What are the uses of Razumab 2.3Mg Injection

    • Wet Form Of Age-Related Macular Degeneration

    Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Ophthalmologist before using this medicine.

    What are the side effects of Razumab 2.3Mg Injection ?

    Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Ophthalmologist before using this medicine.

    Key highlights of Razumab 2.3Mg Injection

    • Is It safe with alcohol?

      Interaction with alcohol is unknown. Please consult your doctor.

    • Are there any pregnancy warnings?

      Razumab 2.3mg injection may be unsafe to use during pregnancy.
      Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.

    • Are there any breast-feeding warnings?

      Razumab 2.3mg injection is probably safe to use during breastfeeding. Please consult your doctor.

    • Is it safe to drive while on this medicine?

      Patients may experience temporary visual disturbances and they should avoid driving or operating machinery.

    • Does this affect kidney function?

      There is no interaction between renal impairment and consuming this drug. So dose alteration is not needed.

    • Does this affect liver function?

      There is no data available. Please consult doctor before consuming the drug.

    Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Ophthalmologist before using this medicine.

    What are the dosage instructions?

    • Are there any missed dose instructions?

      If you miss a dose of Ranibizumab, please consult your doctor.

    Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Ophthalmologist before using this medicine.

    How does this medication work?

    This medicine works by binding to the active forms of VEGF-A along with the biologically active VEGF110. Thus the interaction of VEGF-A with its receptors is inhibited, on the surface of endothelial cells. As a result, endothelial cell multiplication is decreased, and, vascular leakage and new blood vessel formation are also prevented.

      Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Ophthalmologist before using this medicine.

      Disclaimer : The information produced here is best of our knowledge and experience and we have tried our best to make it as accurate and up-to-date as possible, but we would like to request that it should not be treated as a substitute for professional advice, diagnosis or treatment.

      Lybrate is a medium to provide our audience with the common information on medicines and does not guarantee its accuracy or exhaustiveness. Even if there is no mention of a warning for any drug or combination, it never means that we are claiming that the drug or combination is safe for consumption without any proper consultation with an expert.

      Lybrate does not take responsibility for any aspect of medicines or treatments. If you have any doubts about your medication, we strongly recommend you to see a doctor immediately.
      swan-banner
      Sponsored

      Popular Questions & Answers

      View All

      My mother is having eye sight problem. She is u...

      related_content_doctor

      Dr. S.K. Tandon

      General Physician

      Yes if blood sugar and blood pressure is not properly controlled then diabetic retinopathy happen...

      Hi My mother is suffering from CRVO her left ey...

      related_content_doctor

      Dr. Vaibhev Mittal

      Ophthalmologist

      Hello A. All are equally good and equally efficacious Only difference is that avastin is not reco...

      I have retinal brvo and doctor gave me Novartis...

      dr-arun-rajan-ophthalmologist

      Dr. Arun Rajan

      Ophthalmologist

      The drug is Ranibizumab. Accentrix is the trade name. It is administered by injection directly in...

      I am 77 years recently diagnosed for a m d of b...

      related_content_doctor

      Dr. Rajagopal Kunnatur

      Ophthalmologist

      Treatment options include one or more of the following 1. Intravitreal injections (bevacizumab, r...

      Table of content

      Content Details
      Profile Image
      Written ByDrx Hina FirdousPhD (Pharmacology) Pursuing, M.Pharma (Pharmacology), B.Pharma - Certificate in Nutrition and Child CarePharmacology
      Reviewed By
      Profile Image
      Reviewed ByDr. Garima SharmaMBBS, Master in Healthcare Administration, Diploma in Occupational HealthGeneral Physician
      chat_icon

      Ask a free question

      Get FREE multiple opinions from Doctors

      posted anonymously
      swan-banner